Olle Kämpe gets extension as Wallenberg Clinical Scholar
In 2025, five Wallenberg Clinical Scholars have been granted an extended grant for another five years. Among these is KI researcher Olle Kämpe, who will thus receive support for a total of ten years for his research into the causes of autoimmune diseases.
The immune system is supposed to protect us from viruses, bacteria and other microorganisms, but in some people, the system goes wrong and it starts to react against their own body. This causes autoimmune diseases such as type 1 diabetes or Addison's disease.
Professor Olle Kämpe wants to understand what is happening and be able to alleviate and in the long term perhaps stop the effect. The grant as a Wallenberg Clinical Scholar is now being extended by five years and SEK 15 million. The support is of great importance for the continued work.
"This grant provides stability in the long term, something that we wish other funders would emulate. This will give us the conditions to study autoimmune conditions that are self-limiting, in order to better understand which physiological mechanisms can interrupt an attack on the body's own tissue," says Olle Kämpe, professor at the Department of Medicine, Solna, KI and research group leader.
Knut and Alice Wallenberg Foundation is investing almost SEK 600 million over a ten-year period in the research programme Wallenberg Clinical Scholars.
The aim of the programme is to strengthen Swedish clinical research by means of identifying the best clinical researchers, providing them with good conditions to undertake their work, and facilitate the impact of research results in the scientific and healthcare communities.
Wallenberg Clinical Scholars is part of a ten-year initiative undertaken by the Knut and Alice Wallenberg Foundation to strengthen medical research and the life sciences.